Literature DB >> 9582016

Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations.

N Dimitrijevic1, C Winkler, C Wellbrock, A Gómez, J Duschl, J Altschmied, M Schartl.   

Abstract

Xmrk is a receptor tyrosine kinase closely related to the human EGF receptor. In the teleost fish Xiphophorus two versions of the Xmrk gene exist, an oncogene (ONC) and a proto-oncogene (INV). While ONC-Xmrk is the melanoma-inducing gene, INV-Xmrk appears not to be involved in transformation of pigment cells. To elucidate the mechanism that converts the proto-oncogene into a transforming oncogene a comparative analysis of the structure, expression and function of both versions of the gene was performed. In contrast to ONC-Xmrk which is expressed at high levels in melanoma cells, the proto-oncogene INV-Xmrk is ubiquitously expressed at very low levels indicating overexpression as one possible reason for tumorigenicity by ONC-Xmrk. As sequence comparison of the proto-oncogene and the oncogene revealed a number of amino acid changes, a possible effect of these mutations on the activation of the ONC-Xmrk receptor was determined. A constitutive activation of the oncogenic receptor was found and ectopic expression of INV-Xmrk after microinjection into medakafish embryos did not lead to the high tumour rate in transgenic fish as observed for the oncogene. Our data therefore suggest that overexpression of the receptor alone is not sufficient for melanoma induction, but that in addition activating mutations in ONC-Xmrk are responsible for its full tumorigenic potential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582016     DOI: 10.1038/sj.onc.1201693

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Role of epidermal growth factor receptor signaling in RAS-driven melanoma.

Authors:  Nabeel Bardeesy; Minjung Kim; Jin Xu; Ryung-Suk Kim; Qiong Shen; Marcus W Bosenberg; Wing H Wong; Lynda Chin
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

2.  EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.

Authors:  Jennifer Soler Beatty; Cristina Molnar; Carlos M Luque; Jose F de Celis; María D Martín-Bermudo
Journal:  PLoS Genet       Date:  2021-08-19       Impact factor: 5.917

Review 3.  Genetic and environmental melanoma models in fish.

Authors:  E Elizabeth Patton; David L Mitchell; Rodney S Nairn
Journal:  Pigment Cell Melanoma Res       Date:  2010-03-08       Impact factor: 4.693

4.  The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus.

Authors:  S Weis; M Schartl
Journal:  Genetics       Date:  1998-08       Impact factor: 4.562

5.  Transcriptional control analyses of the Xiphophorus melanoma oncogene.

Authors:  Janine Regneri; Jean-Nicolas Volff; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-05       Impact factor: 3.228

6.  Generation of medaka gene knockout models by target-selected mutagenesis.

Authors:  Yoshihito Taniguchi; Shunichi Takeda; Makoto Furutani-Seiki; Yasuhiro Kamei; Takeshi Todo; Takao Sasado; Tomonori Deguchi; Hisato Kondoh; Josine Mudde; Mitsuyoshi Yamazoe; Masayuki Hidaka; Hiroshi Mitani; Atsushi Toyoda; Yoshiyuki Sakaki; Ronald H A Plasterk; Edwin Cuppen
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

Review 7.  Zebrafish cancer: the state of the art and the path forward.

Authors:  Richard White; Kristin Rose; Leonard Zon
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

Review 8.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

9.  Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.

Authors:  Zsofia Miskolczi; Michael P Smith; Emily J Rowling; Jennifer Ferguson; Jorge Barriuso; Claudia Wellbrock
Journal:  Oncogene       Date:  2018-03-16       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.